University · founded 1919

Kettering University

Flint, United States · kettering.edu

Manage this page

Citations, last 5 years: 2 490
Works, last 5 years: 440
h-index: 112
Scientists listed: 28
Grants since 2016: 3 213

Grants received

2018–2022 · career development · K00

System analysis of p53 mutant associated cancer development with LFS patient- specific iPSCs

Huensuk Kim · Kettering University · funded by National Institutes of Health

$77.2k

2018–2022 · research · R01

Dynamics of Primary Cilia Formation During Mammalian Development

Alexandra L. Joyner · Kettering University · funded by National Institutes of Health

$552kGenetic and Kidney Cyst Diseases

2018–2025 · research · R35

Molecular Mechanisms of Drug Resistance in Primary Brain Tumors

Ingo K Mellinghoff · Kettering University · funded by National Institutes of Health

$601k

2018–2022 · research · R01

Understanding tumor addiction to TRK fusions and sensitivity to TRK inhibition

Alexander Drilon · Kettering University · funded by National Institutes of Health

$628.8kMelanoma and MAPK Pathways

2018–2023 · career development · K08

Investigating L1CAM-dependent stem cell regeneration in metastasis

Karuna Ganesh · Kettering University · funded by National Institutes of Health

$256.8k

2018–2023 · career development · K08

Investigating L1CAM-dependent stem cell regeneration in metastasis

Karuna Ganesh · Kettering University · funded by National Institutes of Health

$256.8k

2018–2020 · research · R03

Characterizing the role of glucosamine and chondroitin supplements in the prevention of colorectal tumors

Elizabeth David Kantor · Kettering University · funded by National Institutes of Health

$85.2kProteoglycans and glycosaminoglycans research

2018–2023 · research · R01

Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis

Daniel Bachovchin · Kettering University · funded by National Institutes of Health

$449kInflammasome and immune disorders

2018–2025 · research · R35

Molecular Mechanisms of Drug Resistance in Primary Brain Tumors

Ingo K Mellinghoff · Kettering University · funded by National Institutes of Health

$601k

2018–2023 · career development · K08

Cellular Origins, Molecular Pathogenesis, and Novel Therapeutic Strategies for MAP Kinase-Driven Hematological Malignancies

Benjamin Heath Durham · Kettering University · funded by National Institutes of Health

$208.7kMelanoma and MAPK Pathways

2018–2024 · research · R01

FOOD (Food to Overcome Outcomes Disparities)

Francesca M Gany · Kettering University · funded by National Institutes of Health

$824.1kFood Security and Health in Diverse Populations

2018–2025 · research · R35

Molecular Mechanisms of Drug Resistance in Primary Brain Tumors

Ingo K Mellinghoff · Kettering University · funded by National Institutes of Health

$601k

2018–2021 · research · R01

DOTA-based pre-targeting of alpha emitters

Sarah Marie Cheal · Kettering University · funded by National Institutes of Health

$200.5kRadiopharmaceutical Chemistry and Applications

2018–2021 · research · R01

Renal tubule-specific nanotherapeutics for acute kidney injury

Daniel Alan Heller · Kettering University · funded by National Institutes of Health

$269.4kAcute Kidney Injury Research

2018–2023 · research · R01

Development of optimal strategies to inhibit ERK signaling in tumors with RAF and MEK mutations

David B. Solit · Kettering University · funded by National Institutes of Health

$410.8kMelanoma and MAPK Pathways

2018–2029 · program · P50

SPORE in Soft Tissue Sarcoma

Samuel Singer · Kettering University · funded by National Institutes of Health

$2.4M

2018–2020 · research · R56

A chemical chaperomics platform for AD

Gabriela Chiosis · Kettering University · funded by National Institutes of Health

$904.9k

2018–2021 · research · R01

Dynamics of Primary Cilia Formation During Mammalian Development

Kathryn V Anderson · Kettering University · funded by National Institutes of Health

$552kGenetic and Kidney Cyst Diseases

2018–2025 · research · R35

Molecular Mechanisms of Drug Resistance in Primary Brain Tumors

Ingo K Mellinghoff · Kettering University · funded by National Institutes of Health

$601.1k

2018–2021 · cooperative agreement · UG3

Arylepoxamides: A new class of potent, safer analgesics

Ying-Xian Pan · Kettering University · funded by National Institutes of Health

$3.2M

2018–2023 · research · R01

Understanding tumor addiction to TRK fusions and sensitivity to TRK inhibition

Alexander Drilon · Kettering University · funded by National Institutes of Health

$628.8kMelanoma and MAPK Pathways

2018–2023 · research · R01

Identifying and targeting neoantigens in aggressive salivary carcinomas

Timothy An-Thy Chan · Kettering University · funded by National Institutes of Health

$506.8kSalivary Gland Tumors Diagnosis and Treatment

2018–2019 · fellowship · F32

Role of tissue resident macrophages in development of mammary tumors

Nehemiah Cox · Kettering University · funded by National Institutes of Health

$61.2kImmune cells in cancer

2018–2020 · career development · K99

Hyperpolarized Micro-NMR for Quantitative Analysis of Metabolism in Leukemia Stem Cells

Sangmoo Jeong · Kettering University · funded by National Institutes of Health

$127.6kAdvanced NMR Techniques and Applications

2018–2022 · career development · K00

Evolutionary Heterogeneity of High Grade Glioma

Erik Ladewig · Kettering University · funded by National Institutes of Health

$95.9k

2018–2024 · cooperative agreement · U01

Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer

Lawrence H Schwartz · Kettering University · funded by National Institutes of Health

$566.1kRadiomics and Machine Learning in Medical Imaging

2018–2025 · program · P50

SPORE in Bladder Cancer

Jonathan Eric Rosenberg · Kettering University · funded by National Institutes of Health

$896.3kBladder and Urothelial Cancer Treatments

2018–2022 · research · R01

Identifying and targeting neoantigens in aggressive salivary carcinomas

Timothy An-Thy Chan · Kettering University · funded by National Institutes of Health

$101.8kSalivary Gland Tumors Diagnosis and Treatment

2018–2023 · research · R01

Image-guided TRAIL-enhanced CAR T-cell immunotherapy

Vladimir Ponomarev · Kettering University · funded by National Institutes of Health

$567.8kCAR-T cell therapy research

2018–2024 · program · P50

SPORE in Soft Tissue Sarcoma

Samuel Singer · Kettering University · funded by National Institutes of Health

$2.1MSarcoma Diagnosis and Treatment

2018–2021 · research · R01

Dynamics of Primary Cilia Formation During Mammalian Development

Kathryn V Anderson · Kettering University · funded by National Institutes of Health

$527.7kGenetic and Kidney Cyst Diseases

2018–2023 · research · R01

Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK

Rona Yaeger · Kettering University · funded by National Institutes of Health

$505kMelanoma and MAPK Pathways

2018–2023 · research · R35

Mechanisms of DNA Replication, Chromosome Compaction, and Chromosome Unlinking

Kenneth J Marians · Kettering University · funded by National Institutes of Health

$1M

2018–2023 · research · R01

SANOS (SAlud y Nutricion para todOS)

Jennifer Cf Leng · Kettering University · funded by National Institutes of Health

$871.3k

2018–2021 · fellowship · F32

INVESTIGATING THE MOLECULAR BASIS OF OLAPARIB RESISTANCE IN BRCA2-DEFICIENT PROSTATE CANCER

Kyrie Jean Pappas · Kettering University · funded by National Institutes of Health

$64.3kPARP inhibition in cancer therapy

2018–2022 · research · R01

Understanding tumor addiction to TRK fusions and sensitivity to TRK inhibition

Alexander Drilon · Kettering University · funded by National Institutes of Health

$609.9kMelanoma and MAPK Pathways

2018–2023 · cooperative agreement · U01

Pretargeted Clinical Imaging of CA19.9 in Pancreatic Cancer

Jason S. Lewis · Kettering University · funded by National Institutes of Health

$697.8k

2018–2023 · research · R01

Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK

Rona Yaeger · Kettering University · funded by National Institutes of Health

$505kMelanoma and MAPK Pathways

2018–2023 · research · R01

Identifying and targeting neoantigens in aggressive salivary carcinomas

Timothy An-Thy Chan · Kettering University · funded by National Institutes of Health

$570.9kSalivary Gland Tumors Diagnosis and Treatment

2018–2021 · fellowship · F32

Creating a targeted micropharmacy for improved cellular cancer therapies

Thomas J Gardner · Kettering University · funded by National Institutes of Health

$58.7kCAR-T cell therapy research